Amplifica is a preclinical stage biopharmaceutical company focused on developing novel treatments to address androgenic alopecia.
Amplifica has raised $11.8M in total funding. The most recent round was Series A. The last funding was announced in March 2022.
Amplifica's investors include SternAegis.
Amplifica is headquartered in San Diego, United States.
Amplifica is a preclinical stage biopharmaceutical company focused on developing novel treatments to address androgenic alopecia.
Amplifica is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Amplifica — Funding & Investors." VCBacked, March 1, 2022, https://www.vcbacked.co/company/amplifica-san-diego. Accessed October 21, 2026.
VCBacked. (2022). Amplifica — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/amplifica-san-diego
{{cite web |title=Amplifica — Funding & Investors |url=https://www.vcbacked.co/company/amplifica-san-diego |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated